News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
ThoughtRiver demos AI contract review with 1-click redlines
Legal tech vendor shows product features combining generative AI and ML for contract analysis in live video walkthrough.
Corgi launches AI liability insurance for both vendors and users
Y Combinator-backed insurer offers modular coverage for AI hallucinations, bias claims, and training data disputes as major carriers avoid the space.
Everlaw Partners with Legora for Document-Grounded Legal Drafting
The integration lets attorneys pull discovery documents directly into AI writing tools while drafting witness statements and trial briefs.
AHA launches $12M accelerator for hospital EHR and AI adoption
American Hospital Association partners with West Health to help hospitals implement EHR optimization, virtual care, and AI integration over three years.
Norway's Arctic hospitals cut readmissions with digital care teams
Remote Norwegian hospitals connect specialists to municipal care via video and monitoring, reducing emergency visits and mortality rates.
HIMSS conferences promote tribal health IT with minimal details
Healthcare IT News lists upcoming HIMSS events targeting tribal health leaders but provides no specifics on programs, funding, or participants.
Celcuity breast cancer drug hits endpoints in PIK3CA mutation trial
Gedatolisib succeeded in patients with PIK3CA mutations, setting up broader approval filing for a drug already under FDA review with July decision date.
Cytospire raises $83M for gamma delta T cell engagers
London biotech targets solid tumors with pan-gamma delta T cell engagers, claiming better tumor infiltration than conventional CD3-targeting therapies.
FDA narrows CBER director search to 3-4 final candidates
The agency hopes to fill the key biologics oversight role that has been vacant since September, according to sources familiar with the search.
Vertex kills mRNA cystic fibrosis drug over safety issues
Major CF drugmaker drops genetic medicine program citing tolerability problems that mirror broader mRNA delivery challenges.
Cytokinetics doubles heart drug market after Bristol Myers failure
Drug company succeeds in trial for second form of heart muscle disease, expanding addressable market for hypertrophic cardiomyopathy pill.
Alzheimer's biomarker testing patterns analyzed across 234K patients
Real-world clinical data shows how doctors order and sequence Alzheimer's biomarker tests outside controlled trials, revealing practice variability.